Panel: Data-driven Innovation: 21st Century Public-Private Data Partnerships
Session Recording Description:
Continuing innovation in the exchange and aggregation of large-scale multi-source data assets combined with advanced analytical tools has enabled the exploration of more complex person-centered healthcare questions. This panel discussion will provide an overview of the impact of these advancements on the speed and sophistication of research and improvements in care delivery. You will learn how technology is creating greater data fluidity while maintaining patient privacy, and the ways in which data is being used to move the needle on cost and quality. The panel will discuss how patient organizations are building communities and using data to promote equity and innovation, accelerate research, and apply findings to improve care for patients and populations. Finally, the panel will consider how these learnings can be applied to improve sepsis diagnosis, treatment, and care.
Industry leaders, Public Policy Experts, Health and hospital Leadership (C-Suite, physicians, nurses, pharmacists, CIOs), Health quality and decision support leaders, Health Investors and VCs, Health and Technology Media, Health Advocates, Health Advisors, Health Educators, Health Marketers.
Valerie Barton, MA
Senior Advisor, National Sepsis Registry Initiative
Ms. Valerie Barton is a Senior Advisor with the National Sepsis Registry Initiative (NSRI) where she leads business and operational planning. Ms. Barton has served in leadership roles in data rich-organizations, including at the Patient-Centered Clinical Research Network (PCORnet) where she worked with academic researchers to integrate claims and registry data into the clinical data assets of PCORnet. During her nearly 20 years as a consultant, she assisted clients by bringing data-informed approaches to their health policy development and business strategies. Ms. Barton founded and built research and data practices at both Manatt Health LLP and Avalere Health LLC. Under her leadership, her teams conducted quantitative analytics and economic modeling with observational data for pharmaceutical manufacturers, biotech and medical device firms, patient organizations, and foundations. She began her career as an analyst at the Congressional Budget Office and, later, at the Centers for Medicare and Medicaid Services.
Niall Brennan, MPP
President and Chief Executive Officer, Health Care Cost Institute (HCCI)
Mr. Brennan is the President and CEO of the Health Care Cost Institute. In this role, he is responsible for overseeing HCCI’s overall research agenda that seeks to highlight trends in U.S. health care spending and the factors behind those trends. Niall also works to maximize the reach of HCCI's data by licensing directly to leading academic researchers and through HCCI's role as a Medicare certified Qualified Entity. Niall works closely with federal and state policymakers, including the U.S. Congress on key health policy issues. He is a nationally recognized expert in health care policy, the use of health care data to enable and accelerate health system change, and data transparency. He has published widely in leading academic journals, including the Journal of the American Medical Association, the New England Journal of Medicine and Health Affairs. Prior to joining HCCI, Mr. Brennan was Chief Data Officer at the Centers for Medicare and Medicaid Services (CMS). He has also worked at the Brookings Institution, the Medicare Payment Advisory Commission, the Congressional Budget Office, the Urban Institute, and PriceWaterhouseCoopers. Mr. Brennan received his MPP from Georgetown University and his BA from University College Dublin, Ireland. When not in the office, Niall enjoys spending time with his family, watching soccer and rugby, and road and mountain bike riding.
Jason LaBonte, PhD
Chief Strategy Officer, Datavant
Jason has over 15 years of experience in health information, market research, and commercial benchmarking, and has held executive leadership roles at Decision Resources Group, MedPanel, and UPK. Jason has designed and launched successful new products at every stage of his career. Jason has an AB in Molecular Biology from Princeton and a PhD in Virology from Harvard.
Kristin Schneeman joined FasterCures in April 2005 as director of programs, with primary responsibility for its innovation portfolio of projects and activities, focused on best practices in the funding and conduct of medical research and innovative collaborations among players in the research enterprise. Among other initiatives, she runs the TRAIN (The Research Acceleration and Innovation Network) program, which provides a platform for knowledge sharing and relationship building to support the growth of venture philanthropy in medical research. Kristin brings to FasterCures more than 25 years' experience in public policy, politics, academia, and the media. Schneeman served for three years as a senior adviser and policy director to a gubernatorial candidate in Massachusetts, as a policy aide to a U.S. Congressman, and for four years as the front-line manager and chief-of-staff for a senior adviser to Vice President Al Gore. At Harvard University she directed research projects on future challenges facing governments, and on complex negotiations in business, politics, and international relations. Schneeman began her career as a producer of documentary films, for which she was the recipient of an Emmy Award in 1990.
No continuing education credits are offered for this session.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.